LUPIN
Back to Cashflow Statement
|
LUPIN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-846 Cr | ₹1,732 Cr | ₹-2,184 Cr | ₹-337 Cr | ₹-1,572 Cr |
What is the latest Cash Flow from Financing Activities ratio of LUPIN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-846 Cr |
| Mar2025 | ₹1,732 Cr |
| Mar2024 | ₹-2,184 Cr |
| Mar2023 | ₹-337 Cr |
| Mar2022 | ₹-1,572 Cr |
How is Cash Flow from Financing Activities of LUPIN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-846 Cr | Negative | |
| Mar2025 | ₹1,732 Cr | Positive | |
| Mar2024 | ₹-2,184 Cr | Negative | |
| Mar2023 | ₹-337 Cr | Negative | |
| Mar2022 | ₹-1,572 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹89,587.4 Cr | 0.1% | -6.6% | 0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 0.1% |
-6.6% |
0.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses